Alpha-9 Theranostics
Latest round
- Series C
Last raised
- Oct 2024
Total raised
- $259M
Investors
- 17
About Alpha-9 Theranostics
Based in Canada, Alpha-9 Theranostics Inc.Alpha-9 Theranostics Inc. was founded in 2018 in Vancouver, Canada, and focuses on the development of targeted radiopharmaceuticals.Alpha-9 Theranostics Inc. specializes in developing innovative radiopharmaceuticals aimed at treating cancer with precision. The company’s portfolio includes proprietary molecules that selectively target cancer cells, enhancing treatment efficacy while minimizing damage to healthy tissues. By leveraging a bespoke, iterative approach to optimize critical components such as binders and radioisotopes, Alpha-9's products facilitate faster transitions from research to clinical applications.Alpha-9 Theranostics Inc. generates revenue primarily through strategic partnerships and collaborations with healthcare institutions and pharmaceutical companies in oncology. The business model includes direct sales of radiopharmaceuticals to healthcare providers, as well as B2B transactions with pharmaceutical distributors.In October 2024, Alpha-9 Theranostics Inc. The company plans to launch new products targeting specific cancer types and expand its market reach into additional regions within North America and Europe by 2025, aiming to fulfill the growing demand for innovative cancer therapies.
Who invested in Alpha-9 Theranostics
17 investors across 4 rounds
See all investors in Alpha-9 Theranostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alpha-9 Theranostics
Who invested in Alpha-9 Theranostics?
Alpha-9 Theranostics has 17 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alpha-9 Theranostics raised?
Alpha-9 Theranostics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Alpha-9 Theranostics last raise money?
Alpha-9 Theranostics's most recent round on record is a Series C, in Oct 2024.
What does Alpha-9 Theranostics do?
Based in Canada, Alpha-9 Theranostics Inc.
Where is Alpha-9 Theranostics headquartered?
Alpha-9 Theranostics is headquartered in Vancouver, Canada.
Which VCs invest in companies like Alpha-9 Theranostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Alpha-9 Theranostics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Alpha-9 Theranostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.